Lenalidomide Boosts Overall Survival After Stem Cell Tx – MedPage Today
|
Lenalidomide Boosts Overall Survival After Stem Cell Tx
MedPage Today Lenalidomide (Revlimid) maintenance boosted overall survival (OS) and progression-free survival (PFS) compared with placebo or observation following autologous stem–cell transplantation (ASCT) in patients with newly diagnosed multiple myeloma … |
